201 related articles for article (PubMed ID: 12908755)
1. Recurrent and atypical meningiomas--a multiparametric study using Ki67 labelling index, AgNOR and DNA Feulgen staining.
Ferraraccio F; Accardo M; Giangaspero F; Cuccurullo L
Clin Neuropathol; 2003; 22(4):187-92. PubMed ID: 12908755
[TBL] [Abstract][Full Text] [Related]
2. Assessment of proliferative potential of meningiomas using PCNA LI and AgNOR counts.
Sudha K; Karak AK; Sharma MC; Mathur M; Sarkar C
Indian J Pathol Microbiol; 1998 Jul; 41(3):323-30. PubMed ID: 9805855
[TBL] [Abstract][Full Text] [Related]
3. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
Roser F; Samii M; Ostertag H; Bellinzona M
Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
[TBL] [Abstract][Full Text] [Related]
4. The significance of nucleolar organizer region (AgNOR) score in predicting meningioma recurrence.
Kunishio K; Ohmoto T; Matsuhisa T; Maeshiro T; Furuta T; Matsumoto K
Cancer; 1994 Apr; 73(8):2200-5. PubMed ID: 8156526
[TBL] [Abstract][Full Text] [Related]
5. Meningiomas: correlation of Ki67 with histological grade.
Babu S; Uppin SG; Uppin MS; Panigrahi MK; Saradhi V; Bhattacharjee S; Sahu BP; Purohit AK; Challa S
Neurol India; 2011; 59(2):204-7. PubMed ID: 21483118
[TBL] [Abstract][Full Text] [Related]
6. Correlation of DNA content and nucleomorphometric features with World Health Organization grading of meningiomas.
Grunewald JP; Röhl FW; Kirches E; Dietzmann K
Mod Pathol; 1998 Feb; 11(2):216-23. PubMed ID: 9504694
[TBL] [Abstract][Full Text] [Related]
7. Quantitative evaluation of recurrent meningiomas.
Scarpelli M; Montironi R; Sisti S; Mariuzzi GM; Brancorsini D; Collan Y; Rychlicki F; Ansuini G
Pathol Res Pract; 1989 Nov; 185(5):746-51. PubMed ID: 2626384
[TBL] [Abstract][Full Text] [Related]
8. Comparative investigation of proliferation markers and their prognostic relevance in human meningiomas.
Torp SH; Lindboe CF; Granli US; Moen TM; Nordtømme T
Clin Neuropathol; 2001; 20(5):190-5. PubMed ID: 11594503
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of argyrophilic nucleolar organizer region staining in predicting the behavior of meningiomas.
Ahmadi SA; Samadi N
Ann Saudi Med; 2006; 26(1):38-42. PubMed ID: 16521873
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic validity of the Ki-67 labeling index using the MIB-1 monoclonal antibody in the grading of meningiomas.
Devaprasath A; Chacko G
Neurol India; 2003 Sep; 51(3):336-40. PubMed ID: 14652433
[TBL] [Abstract][Full Text] [Related]
11. The use of digital cell image analysis of Feulgen-stained nuclei to quantitatively describe morphonuclear features in a series of 174 meningiomas.
Salmon I; Camby I; Gras T; Rombaut K; Pasteels JL; Kiss R
Mod Pathol; 1994 Jun; 7(5):570-7. PubMed ID: 7524069
[TBL] [Abstract][Full Text] [Related]
12. Proliferating cell nuclear antigen (PCNA) and nucleolar organizer regions (NORs) in benign, atypical and malignant meningiomas.
Lee MC; Kang MW; Yang BS; Park CS; Juhng SW; Jung S; Kim JH; Kim SH; Kang SS; Lee JH
Noshuyo Byori; 1995; 12(2):133-9. PubMed ID: 8867694
[TBL] [Abstract][Full Text] [Related]
13. [Nucleolar organizer regions in meningiomas with reference to histopathological findings and recurrence].
Hirayama H; Hara A; Niikawa S; Iwai T; Nishimura Y; Ando T; Sakai N; Yamada H; Takada M
No To Shinkei; 1993 Apr; 45(4):355-61. PubMed ID: 8334021
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas.
Amatya VJ; Takeshima Y; Sugiyama K; Kurisu K; Nishisaka T; Fukuhara T; Inai K
Hum Pathol; 2001 Sep; 32(9):970-5. PubMed ID: 11567227
[TBL] [Abstract][Full Text] [Related]
15. [DNA analysis of meningiomas using paraffin-embedded surgical specimens in connection with clinical recurrence].
Akachi K; Matsumoto M; Yasue M; Nakamura N; Kamada M; Ohno T
No Shinkei Geka; 1991 Dec; 19(12):1129-34. PubMed ID: 1766537
[TBL] [Abstract][Full Text] [Related]
16. The significance of Ki-67/MIB-1 labeling index in human meningiomas: a literature study.
Abry E; Thomassen IØ; Salvesen ØO; Torp SH
Pathol Res Pract; 2010 Dec; 206(12):810-5. PubMed ID: 20951502
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of Ki-67/MIB-1 proliferation index in meningiomas.
Torp SH; Lindboe CF; Grønberg BH; Lydersen S; Sundstrøm S
Clin Neuropathol; 2005; 24(4):170-4. PubMed ID: 16033133
[TBL] [Abstract][Full Text] [Related]
18. PCNA, Ki-67 and hTERT in residual benign meningiomas.
Maes L; Kalala JP; Cornelissen M; De Ridder L
In Vivo; 2006; 20(2):271-5. PubMed ID: 16634530
[TBL] [Abstract][Full Text] [Related]
19. [Clinical study on the recurrence of meningiomas: correlating factors for the recurrence and therapeutic prognosis of meningiomas].
Miyagami M; Miyagi A; Kido G; Tsubokawa T
No Shinkei Geka; 1994 May; 22(5):421-8. PubMed ID: 8196827
[TBL] [Abstract][Full Text] [Related]
20. The application of flow cytometry for evaluating biological aggressiveness of intracranial meningiomas.
Lin YW; Tai SH; Huang YH; Chang CC; Juan WS; Chao LC; Wen MJ; Hung YC; Lee EJ
Cytometry B Clin Cytom; 2015; 88(5):312-9. PubMed ID: 25408130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
